Download PDF
Am J Perinatol 2015; 32(02): 187-192
DOI: 10.1055/s-0034-1381721
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Labor Outcomes of Obese Patients Undergoing Induction of Labor with Misoprostol compared to Dinoprostone

Rudy S. Suidan
1   Department of Obstetrics, Gynecology, and Women's Health, Rutgers, New Jersey Medical School/University Hospital, Newark, New Jersey
,
Kaylah C. Rondon
1   Department of Obstetrics, Gynecology, and Women's Health, Rutgers, New Jersey Medical School/University Hospital, Newark, New Jersey
,
Joseph J. Apuzzio
1   Department of Obstetrics, Gynecology, and Women's Health, Rutgers, New Jersey Medical School/University Hospital, Newark, New Jersey
,
Shauna F. Williams
1   Department of Obstetrics, Gynecology, and Women's Health, Rutgers, New Jersey Medical School/University Hospital, Newark, New Jersey
› Author Affiliations
Further Information

Publication History

07 April 2014

22 April 2014

Publication Date:
10 June 2014 (online)

Also available at
    Permissions and Reprints

Abstract

Objective The aim of the article is to evaluate and compare labor outcomes in obese patients undergoing induction of labor (IOL) with misoprostol and dinoprostone.

Study Design This was a retrospective review of patients who delivered from February 1, 2008, to July 1, 2013 at our institution. All obese women who underwent IOL were identified. The rates of successful cervical ripening and cesarean delivery (CD) for patients who underwent IOL with misoprostol and dinoprostone were calculated and compared.

Results A total of 564 women met inclusion criteria; 297 (52.7%) were induced with misoprostol, and 267 (47.3%) were induced with dinoprostone. The misoprostol group had a higher successful cervical ripening rate (78.1 vs. 66.7%; odds ratio [OR], 1.79; 95% confidence interval [CI], 1.23–2.6; p = 0.002) and a lower CD rate (39.1 vs. 51.3%; OR, 0.61; 95% CI, 0.44–0.85; p = 0.003) than the dinoprostone group. This significance persisted in a multivariate model adjusting for parity, gestational age, birth weight, and indication for IOL. The rates of tachysystole, terbutaline use, postpartum hemorrhage, and infectious morbidity were comparable in both groups, as were Apgar scores, rates of neonatal intensive care unit admission, and meconium passage.

Conclusion In obese women undergoing IOL, misoprostol leads to a higher successful cervical ripening rate and a lower CD rate than dinoprostone, with a similar rate of peripartum complications and neonatal outcomes.

Keywords

obesity - induction of labor - cesarean delivery - misoprostol - dinoprostone
 

  • References

  • 1 Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity among adults: United States, 2011-2012. NCHS Data Brief 2013; 131 (131) 1-8
    PubMedSearch in Google Scholar
  • 2 Weiss JL, Malone FD, Emig D , et al; FASTER Research Consortium. Obesity, obstetric complications and cesarean delivery rate—a population-based screening study. Am J Obstet Gynecol 2004; 190 (4) 1091-1097
    CrossrefPubMedSearch in Google Scholar
  • 3 Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 2004; 103 (2) 219-224
    CrossrefPubMedSearch in Google Scholar
  • 4 Vahratian A, Zhang J, Troendle JF, Savitz DA, Siega-Riz AM. Maternal prepregnancy overweight and obesity and the pattern of labor progression in term nulliparous women. Obstet Gynecol 2004; 104 (5 Pt 1) 943-951
    CrossrefPubMedSearch in Google Scholar
  • 5 Martin JA, Hamilton BE, Ventura SJ, Osterman MJK, Mathews TJ. Births: Final Data for 2011. National Vital Statistics Reports; vol 62 no 1. Hyattsville, MD: National Center for Health Statistics; 2013
    Search in Google Scholar
  • 6 ACOG Practice Bulletin No. 107: Induction of labor. Obstet Gynecol 2009; 114 (2 Pt 1) 386-397
    CrossrefPubMedSearch in Google Scholar
  • 7 Ramsey PS, Harris DY, Ogburn Jr PL, Heise RH, Magtibay PM, Ramin KD. Comparative efficacy and cost of the prostaglandin analogs dinoprostone and misoprostol as labor preinduction agents. Am J Obstet Gynecol 2003; 188 (2) 560-565
    CrossrefPubMedSearch in Google Scholar
  • 8 Dällenbach P, Boulvain M, Viardot C, Irion O. Oral misoprostol or vaginal dinoprostone for labor induction: a randomized controlled trial. Am J Obstet Gynecol 2003; 188 (1) 162-167
    CrossrefPubMedSearch in Google Scholar
  • 9 Prager M, Eneroth-Grimfors E, Edlund M, Marions L. A randomised controlled trial of intravaginal dinoprostone, intravaginal misoprostol and transcervical balloon catheter for labour induction. BJOG 2008; 115 (11) 1443-1450
    CrossrefPubMedSearch in Google Scholar
  • 10 Faucett AM, Daniels K, Lee HC, El-Sayed YY, Blumenfeld YJ. Oral misoprostol versus vaginal dinoprostone for labor induction in nulliparous women at term. J Perinatol 2014; 34 (2) 95-99
    CrossrefPubMedSearch in Google Scholar
  • 11 Abraham C, Meirowitz N, Kohn N. Labor induction for premature rupture of membranes using vaginal misoprostol versus dinoprostone vaginal insert. Am J Perinatol 2014; 31 (3) 181-186
    Thieme ConnectPubMedSearch in Google Scholar
  • 12 Wolfe KB, Rossi RA, Warshak CR. The effect of maternal obesity on the rate of failed induction of labor. Am J Obstet Gynecol 2011; 205 (2) e1-e7
    CrossrefPubMedSearch in Google Scholar
  • 13 Martínez ME, Heddens D, Earnest DL , et al. Physical activity, body mass index, and prostaglandin E2 levels in rectal mucosa. J Natl Cancer Inst 1999; 91 (11) 950-953
    CrossrefPubMedSearch in Google Scholar
  • 14 Richelsen B. Prostaglandin E2 action and binding in human adipocytes: effects of sex, age, and obesity. Metabolism 1988; 37 (3) 268-275
    CrossrefPubMedSearch in Google Scholar
  • 15 Subbaramaiah K, Morris PG, Zhou XK , et al. Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. Cancer Discov 2012; 2 (4) 356-365
    CrossrefPubMedSearch in Google Scholar
  • 16 Clark EAS, Silver RM. Long-term maternal morbidity associated with repeat cesarean delivery. Am J Obstet Gynecol 2011; 205 (6, Suppl): S2-S10
    CrossrefPubMedSearch in Google Scholar
  • 17 Spong CY, Berghella V, Wenstrom KD, Mercer BM, Saade GR. Preventing the first cesarean delivery: summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, and American College of Obstetricians and Gynecologists Workshop. Obstet Gynecol 2012; 120 (5) 1181-1193
    CrossrefPubMedSearch in Google Scholar
  • 18 Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307 (5) 491-497
    CrossrefPubMedSearch in Google Scholar